David J. Gury
Director/Board Member at Scripps Florida Funding Corp.
David J. Gury active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Gury Consulting LLC | Corporate Officer/Principal | 31/05/2004 | - |
| Scripps Florida Funding Corp. | Director/Board Member | 31/03/2005 | - |
| Florida Atlantic University Foundation, Inc. | Treasurer | - | - |
Career history of David J. Gury
Former positions of David J. Gury
| Companies | Position | Start | End |
|---|---|---|---|
| U.S. STEM CELL, INC. | Director/Board Member | 30/06/2005 | 06/01/2009 |
| ORAGENICS, INC. | Chairman | 30/09/2003 | 07/04/2008 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Chairman | 30/04/1984 | 30/04/2004 |
| President | 30/04/1984 | 30/04/2004 | |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Chairman | - | - |
Training of David J. Gury
| The University of Chicago | Masters Business Admin |
| Kenyon College | Undergraduate Degree |
Statistics
International
| United States | 10 |
Operational
| Chairman | 3 |
| Director/Board Member | 2 |
| President | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ORAGENICS, INC. | Health Technology |
| U.S. STEM CELL, INC. | Health Services |
| Private companies | 5 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
| Scripps Florida Funding Corp. | |
| Florida Atlantic University Foundation, Inc. | |
| Gury Consulting LLC |
- Stock Market
- Insiders
- David J. Gury
- Experience
